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Abstract
The mechanical properties of the cell nucleus are increasingly recognized as critical in many 
biological processes. The deformability of the nucleus determines the ability of immune and 
cancer cells to migrate through tissues and across endothelial cell layers, and changes to the 
mechanical properties of the nucleus can serve as novel biomarkers in processes such as cancer 
progression and stem cell differentiation. However, current techniques to measure the viscoelastic 
nuclear mechanical properties are often time consuming, limited to probing one cell at a time, or 
require expensive, highly specialized equipment. Furthermore, many current assays do not 
measure time-dependent properties, which are characteristic of viscoelastic materials. Here, we 
present an easy-to-use microfluidic device that applies the well-established approach of 
micropipette aspiration, adapted to measure many cells in parallel. The device design allows rapid 
loading and purging of cells for measurements, and minimizes clogging by large particles or 
clusters of cells. Combined with a semi-automated image analysis pipeline, the microfluidic 
device approach enables significantly increased experimental throughput. We validated the 
experimental platform by comparing computational models of the fluid mechanics in the device 
with experimental measurements of fluid flow. In addition, we conducted experiments on cells 
lacking the nuclear envelope protein lamin A/C and wild-type controls, which have well-
characterized nuclear mechanical properties. Fitting time-dependent nuclear deformation data to 
power law and different viscoelastic models revealed that loss of lamin A/C significantly altered 
the elastic and viscous properties of the nucleus, resulting in substantially increased nuclear 
deformability. Lastly, to demonstrate the versatility of the devices, we characterized the 
viscoelastic nuclear mechanical properties in a variety of cell lines and experimental model 
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systems, including human skin fibroblasts from an individual with a mutation in the lamin gene 
associated with dilated cardiomyopathy, healthy control fibroblasts, induced pluripotent stem cells 
(iPSCs), and human tumor cells. Taken together, these experiments demonstrate the ability of the 
microfluidic device and automated image analysis platform to provide robust, high throughput 
measurements of nuclear mechanical properties, including time-dependent elastic and viscous 
behavior, in a broad range of applications.
Introduction
The nucleus is the largest and stiffest organelle of eukaryotic cells. The mechanical 
properties of the nucleus are primarily determined by the nuclear lamina, a dense protein 
network comprised of lamins that underlies the inner nuclear membrane, and chromatin.1–4 
Chromatin mechanics dominate the overall nuclear response for small deformations, 
whereas the lamina governs the nuclear response for larger deformations.3,4 In recent years, 
the mechanical properties of the nucleus have emerged as important predictors and 
biomarkers for numerous physiological and pathological conditions and functions, raising 
increased interest in probing nuclear mechanics. For example, the deformability of the 
nucleus determines the ability of migrating cells to pass through small openings,5–8 which is 
highly relevant during development, immune cell infiltration, and cancer metastasis, where 
cells move through tight interstitial spaces and enter and exit blood vessels through openings 
only a few micrometer in diameter.9 In stem cell applications, the morphology and 
mechanical properties of the nucleus can serve as label-free biomarkers for differentiation,
10–12 reflecting characteristic changes in the composition of the nuclear envelope and 
chromatin organization during differentiation.10,13,14 Lastly, mutations in the genes 
encoding lamins give rise to a large family of inheritable disorders termed laminopathies, 
which are often characterized by reduced nuclear stability.15
The mechanical properties of cells and their nuclei are assessed using a range of techniques. 
Nuclear deformation can be observed by stretching cells cultured on flexible membranes and 
used to infer the mechanical properties of the nucleus, including the contribution of specific 
nuclear envelope proteins.16–19 However, this technique relies on nucleo-cytoskeletal 
connections to transmit forces to the nucleus, which may be affected by mutations in nuclear 
lamins,20 and stretching cells requires strong adhesion to the substrate. The latter fact limits 
the type of cells that can be studied, and can result in bias towards sub-populations of 
strongly adherent cells.19 Single cell techniques, such as atomic force microscopy (AFM), 
nuclear stretching between two micropipettes,4 and magnetic bead microrheology,21 apply 
precisely controlled forces and measure the induced deformation, thus providing detailed 
information on nuclear mechanical properties. However, these techniques are time-
consuming, technically challenging, and often require expensive equipment and training.
Micropipette aspiration remains one of the gold standards and most commonly used tools to 
study nuclear mechanics22–24 and provides important information on the viscoelastic 
behavior of the nucleus over different time scales.13,25 Micropipette aspiration has been used 
to study a wide variety of phenomena, including the mechanical properties of the 
nucleus2,25, the exclusion of nucleoplasm from chromatin,26 and chromatin stretching27 
during nuclear deformation. However, micropipette aspiration is traditionally limited to a 
single cell at a time and performed with custom-pulled glass pipettes, which often vary in 
shape and diameter. In contrast, microfluidic devices enable high-throughput measurements 
of nuclear and cellular mechanics with precisely defined geometries.28–30 Some microfluidic 
devices measure the stiffness of cells based on their transit time when perfused through 
narrow constrictions31–34 or mimic micropipette aspiration,35 but these approaches are often 
hampered by clogging due to particles, large cell aggregates, or cell adhesion in the 
constrictions. This problem can be alleviated in devices that use fluid shear stress to deform 
the cells rather than constrictions,36 but the deformations achieved in these devices do not 
recapitulate the extensive deformations that can be achieved using physical barriers. 
Furthermore, in many of the current microfluidic perfusion assays, nuclear deformation is 
measured for only fractions of a second, making it difficult to observe viscoelastic responses 
with longer time-scales. Recently, it was shown that chromatin dominates the viscoelastic 
response for time scales beyond 3.5 s,4 it is therefore important to address nuclear 
mechanics at this time scale, which micropipettes are well suited for.
To overcome these challenges, we have developed an easy-to-use microfluidic device to 
measure time-dependent nuclear mechanical properties in a high-throughput manner. Our 
device prevents common issues such as clogging by positioning the micropipette channels 
away from the main flow, so that large clumps of cells and debris are less likely to reach the 
channels than the target single cells. The device enables robust measurements of many cells 
in parallel and requires minimal specialized equipment. Our system with two pressure inputs 
provides precise (yet simple) control of the micropipette loading speed and the pressure 
applied to the nuclei, while allowing us to easily clear the micropipette channels from debris 
and previously aspirated cells, which are swept away to the waste. Combined with a custom-
developed automated image analysis MATLAB program to further accelerate the analysis 
and to provide consistent measurements, this experimental platform enables analysis of 
100’s of cells per hour, representing a 10- to 40-fold improvement over conventional manual 
micropipette aspiration.37 We demonstrate the device’s utility to quantify time-dependent 
nuclear and cell mechanics on a single-cell level, in a high throughput manner, in a broad 
range of applications and cell types.
Materials and Methods
Cells used for experiments.
Mouse embryonic fibroblasts (MEFs) with homozygous deletion of the Lmna gene, which 
encodes lamins A/C, along with wild-type littermate controls, were generously provided by 
Dr. Colin Stewart.38 Wild-type MEFs were stably modified with lentiviral vectors to express 
mNeonGreen-Histone 2B,39 as described previously.40 HT1080 cells were purchased from 
the DSMZ Braunschweig, Germany, and stably modified with lentiviral vectors to express 
the nuclear rupture reporter NLS-GFP, as described previously.41 Induced pluripotent stem 
cells (iPSC) and healthy human skin fibroblasts were generously provided by Elisa di 
Pasquale and Gianluigi Condorelli (Humanitas Clinical and Research Center, Italy).42 MDA-
MB-231 cells were obtained from the American Type Culture Collection (ATCC). MEF, 
HT-1080, MDA-MB-231, and human fibroblast cells were maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10 % (v/v) fetal bovine serum and 
1 % (v/v) penicillin/streptomycin. iPSCs were maintained on matrigel-coated dishes in 
mTeSR medium (Stem Cell Technologies), prepared according to manufacturer’s 
instruction. The dishes were prepared by diluting 50 μl matrigel (BD 354277) in 1 ml of 
mTeSR and incubating in 35 mm plastic petri dishes overnight at 4°C.
Design and microfabrication of the microfluidic devices.
The mask and wafers were produced in the Cornell NanoScale Science and Technology 
Facility (CNF). The masks were fabricated using a Heidelberg DWL 2000 Mask Writer. 
Since the device contains features with different heights (5 μm for the micropipette channels 
and 10 μm for larger perfusion channels), two SU8 photolithography steps were used. A first 
5-μm tall layer consisting of only the micropipettes channels was created by spinning SU-8
2005 to the correct thickness and exposing through the photomask using a GCA Autostep
200 DSW i-line Wafer Stepper, which allows precise realignment of the mask and wafer
within 1 μm when using masks for the different SU-8 layers. The wafer was baked at 95°C
for 30 minutes, cooled down and developed in SU-8 developer. A second layer of SU-8 2007
was spun to a thickness of 10 μm, and the larger device features were exposed on the
stepper. The wafers were subsequently baked, developed following standard
photolithography procedures,40 and coated with trichloro(1H, 1H, 2H, 2H-
perfluorooctyl)silane to facilitate demolding. PDMS replicas of the devices were cast using
Sylgard 184 (Dow Corning), mixing in a 10:1 ratio and baking for two hours at 65°C. To
minimize wear to the original wafer, the first PDMS cast was used to create a plastic mold
from which all subsequent PDMS replicas were made, following a previously published
protocol.43 PDMS replicas were cut into individual devices and holes for perfusion were cut
into the PDMS using a small (0.75 or 1.2 mm) biopsy punch to introduce tubing. The final
PDMS devices were then mounted on glass slides using a plasma cleaner (Harrick Plasma)
as described previously.5,40
Experimental acquisition.
Immediately after plasma treatment, the PDMS devices were filled with 20 mg/ml bovine 
serum albumin (BSA) and 0.2% (v/v) fetal bovine serum (FBS) in phosphate buffered saline 
(PBS) for 10 minutes to passivate the device. The same PBS solution was used as perfusion 
buffer and to create a cell suspension. The cell suspension (5 million cells/ml) was prepared 
in the PBS solution and kept on ice. Cell nuclei were stained by adding an aliquot of 
Hoechst 33342 at a dilution of 1:1000 to the cell suspension for a final concentration of 10 
μg/ml and incubated on ice for ten minutes before being used for experiments. The vial with 
the cell suspension was connected via Tygon S3 E-3603 tubing (VWR, inner diameter 1/32”; 
outer diameter 3/32”) to the cell entry port of the microfluidic device; a vial with cell free 
PBS solution (perfusion buffer) was connected to the buffer port. Additional tubing was 
connected to the outlet port (Patm in Figure 1A) and drained into a small collection tube. The 
pressure applied to the vials with the cell suspension and the perfusion buffer was adjusted 
using an MCFS-EZ pressure controller (Fluigent) to regulate cell/buffer perfusion into the 
device. For the experiments, a pressure of 7.0 kPa was applied to the cell suspension and 1.4 
kPa to the buffer solution. The outlet port tubing was open to atmospheric pressure.
Brightfield and fluorescence images of cells in the micropipette channels were acquired 
every 5 seconds using a 20×/NA 0.8 air objective and ORCA Flash 4.0 V2 Deep Cooling 
sCMOS (Hamamatsu) or alternatively CoolSNAP KINO CCD (Photometrics) digital camera 
to record nuclear deformation. At the start of each acquisition, cells present in the device 
were ejected from the micropipette channels, allowing new cells to enter the cell pockets and 
micropipette channels. To eject cells, pressure was applied to the outlet port with a syringe 
or pipette inserted in the tubing, causing transient reversal of the flow in the micropipette 
channels. As the pressure is greater at the cell port than the buffer port, the ejected cells were 
swept away from the vicinity of the micropipette channels towards the buffer port. After 
these cells had been removed (as observed through the microscope), the pressure at the 
outlet port was released, allowing new cells to enter the cell pockets and micropipette 
channels (Suppl. Movie 1). The next round of data acquisition was then performed with 
these cells. By commencing the image acquisition before ejecting the cells, we ensured that 
all stages of cell and nuclear deformation were captured in the image sequences. The above 
procedure was repeated several times to capture data for a large number of cells at each 
experimental condition.
Modeling and experimental validation of fluid dynamics in the microfluidic devices.
To determine the pressure exerted on the cells during nuclear deformation in the micro-
channels, and because physical measurements inside the device are not feasible, we 
computationally modeled the pressure distribution inside the devices. Using the finite 
elements modeling software COMSOL Multiphysics 5.2, we designed a three-dimensional 
(3D) model that reproduced the geometry of the device. The fluid flow in the device was 
considered as laminar flow following the Navier-Stokes equation:
ρ u . ∇ u = ∇ − pI + η ∇u + ∇u T
(1)
in which ρ is the volumic mass, u is the velocity, p is the pressure, I is the identity matrix 
and η is the dynamic viscosity of the fluid. The operator T, indicates the transpose operation 
on a tensor.
The hydrodynamic resistance of a tubular channel with laminar flow scales with the length 
of the channel and the inverse of the channel radius to the fourth power. Since the cross-
sectional area of the tubing connecting the pressure controller to the device is orders of 
magnitude larger than the cross-sectional area of the channels in the microfluidic device, the 
hydrodynamic resistance of the microfluidic device is much greater than that of the 
connecting tubing. The pressure drop across the tubing outside of the microfluidic devices 
was therefore considered negligible relative to the pressure drop inside the device. The 
boundary conditions of the model were thus set to the pressure values applied to each 
solution in the device (PCell = 7 kPa; PBuffer = 1.4 kPa). From this simulation, we computed 
the pressure distribution and the corresponding fluid flow profile in the device. The 
simulated velocity field was averaged over surfaces located above the center of each pocket, 
to remove any effects due to variation in the geometry.
To validate our computational model, we experimentally determined the flow rates from the 
streaks created by fluorescent beads (1.9 μm diameter) over a 3 ms exposure time. The 
length of the streaks was measured using ImageJ (National Institutes of Health, https://
imagej.nih.gov/ij/). To minimize the effect of bead interactions with the walls, we analyzed 
only beads in the center of the channel. Given the small dimensions of the microfluidic 
channels, we calculated the effect of the beads on the effective viscosity of the fluid, using 
the work of Heinen et al.44 and Einstein’s formula:
η = ηs 1 + 2.5ϕ
(2)
in which ηs represents the dynamic viscosity of the fluid alone, and ϕ is the volume fraction 
of beads in the fluid. In our experiments, we used a 0.01% vol/vol suspension of beads with 
1.9 μm diameter (Thermo-Fisher, Fluoro-Max G0200) in PBS solution with 20 mg/ml BSA. 
The viscosity for PBS containing 20 mg/ml BSA is ηs = 1.12 mPa.s.44 Using the above 
equation, the dynamic viscosity of the bead/PBS suspension was determined from equation 
(2) to be η = 1.148 mPa.s. The flow rates in the channels were then computed from equation
(1) using the bead velocity, pressure, and the viscosity of the bead solution.
Automated analysis of nuclear deformability measurements.
A custom-written MATLAB program (available at: https://github.com/Lammerding/
MATLAB-micropipette_analysis) was used to compute nuclear deformation into the 
microfluidic micropipette channels with only minimal user intervention. The MATLAB 
script converts time-lapse micropipette aspiration movies obtained using ZEN software 
(Zeiss) into multidimensional TIF stacks, separated according to color channels. The 
program can be readily adapted to import time-lapse sequences in other formats. The 
program automatically aligns the image sequence to a mask of the microfluidic device 
features to correct the images for rotational error, segment the individual microfluidic 
pockets, and determine the location of the micropipette channel entrances. The user can 
make manual fine adjustments to the micropipette entrance line at any time using the arrow 
keys in the program interface. The program then thresholds the blue color channel, which 
corresponds to the blue fluorescence from the DNA-binding Hoechst 33342 dye, to provide 
a trace of the nucleus during deformation. The threshold for the nuclear segmentation is 
based on a manual graphical user interface that provides a preview of the segmentation. To 
account for the heterogeneity in the Hoechst signal across different nuclei, the user selects a 
binary threshold value for each pocket from a histogram of pixel count versus intensity. 
After applying erosion and dilation processing to smooth the outlines of each thresholded 
nucleus, the program employs the MATLAB’s regionprops function to track the nucleus’ 
leading edge inside the micropipette and calculate the distance between the leading edge of 
the nucleus and the micropipette channel entrance for each frame. The program allows for 
visual inspection of the nuclear protrusion length analysis. After analyzing all nuclei, the 
program exports the final matrix of nuclear protrusion values over time into a Microsoft 
Excel-compatible file, where rows correspond to the pocket number and columns to each 
image frame/time point. Empty pockets register as zeroes. Likewise, once a nucleus deforms 
past the end of the micropipette channel, it also registers as zero since the protrusion length 
is no longer measureable. For cells with highly deformable nuclei, multiple cells may 
sequentially enter and pass through a given micropipette channel during a single acquisition 
sequence. These cells are recorded as separate events. An additional MATLAB script, 
available upon request, was used to transpose the protrusion length versus time data to make 
it suitable for multilevel model analysis using JMP software.
Fitting the deformation data to models.
The data obtained in the deformation experiments were fit to a number of viscoelastic 
models using the solver function in Microsoft Excel. Briefly, the function corresponding to 
the model studied was determined and approximate values for the variables were chosen as 
starting values. A computed value of the protrusion length was then obtained for each given 
deformation time, based on the function and variables. Each of these calculated values was 
subtracted from the value of the protrusion length obtained experimentally at each time 
point. This residual value was squared and the sum of squares for all time points was used as 
an indicator of goodness-of-fit. The solver function in Microsoft Excel was used to minimize 
the sum of the squared residuals by varying the variables within each model.
Each data set was modeled using six separate functions. We tested two functions for the 
power law model: y = A * t α and y = A * t α + c. We tested four functions for the modified 
spring-and-dashpot model: the Kelvin–Voigt model (spring and dashpot in parallel) y = A * 
(1 – exp(B * t)), the linear model (a spring followed by a spring and dashpot in parallel) y = 
A – B*(1 – exp(C * t)), a Jeffreys model (a dashpot followed by a spring and dashpot in 
parallel) y = A * (1 – exp(B * t)) + C * t, and a Burgers model (a spring and dashpot in 
series followed by a spring and dashpot in parallel) y = A – B * (1 – exp(C * t)) + D * t. In 
the results section we report the second power law model and the Jeffreys model, which both 
showed significant improvements over more simple models. The Burgers model did not 
greatly improve the sum of the residuals, and thus we chose the Jeffreys model. The 
viscosity and elastic modulus were derived from these variables as detailed in the 
Supplementary information. We calculated and report the coefficient of determination (R2) 
value for each model and cell type.
Statistical analysis.
Statistical analysis was performed using Microsoft Excel and Igor Pro. We determined p 
values in student t-tests using the TTEST function in Excel. Igor Pro was used to obtain the 
confidence interval (one standard deviation) on the variables obtained from the fit of the data 
to the various models. Standard error propagation calculations were performed to obtain 
error values on the spring constants, elastic moduli, and viscosities, estimating that the error 
on the pressure is 0.3 kPa, and the error on the width and height of the micropipette channels 
is 0.5 μm. In all figures, error bars represent the standard error of the mean unless indicated 
otherwise. All data are based on at least two independent experiments.
Results and discussion
Design of the microfluidic devices
The device consists of a series of 18 pockets with small micropipette channels, abutting a 
larger main channel used to perfuse cells into the device and the individual pockets (Figure 
1A–D). The pockets are 20 μm wide and 10 μm tall, thus large enough to hold only a single 
cell. The micropipette channels are 3 μm wide and 5 μm tall, similar in size to micropipettes 
in conventional micropipette aspiration assays for probing nuclear mechanics, in which 
pulled glass pipettes with 3–5 μm inner diameter are used.2,25,45 The micropipette channels 
connect to a large chamber at atmospheric pressure (Patm). The cells are introduced into the 
device at the cell port under a pressure (PCell) that is higher than the pressure at the buffer 
port (PBuffer), ensuring that the cells flow along the main channel (Figure 1A, C and D.) The 
two pressure inlets allow precise control of the velocity of the perfusion of the cells through 
the devices and the pressure applied on the cells in the pockets and micropipette channels. 
Microfluidic filters at each port, consisting of arrays of pillars, prevent large clusters of cells 
or dust to enter the main channel. As cells perfuse through the device, single cells flow into 
empty pockets and block the entrance of the micropipette channels, thereby preventing 
additional cells from settling into the same pocket. Cells located in the pocket then deform 
into the micropipette channels as they are subjected to the pressure difference between the 
main channel and atmospheric pressure. The large cell nucleus fills the entire cross-section 
of the micropipette channel (Figure 1E). The externally applied pressure is kept constant and 
the nucleus gradually enters the micropipette channel, closely resembling the creep behavior 
observed in conventional micropipette aspiration assay.22,37 The deformation of the nucleus 
over time is recorded by time-lapse microscopy and used to infer the mechanical properties 
of the nucleus. Our micropipette dimensions are optimized for fibroblasts, myoblasts, and 
most cancer cells. The design can readily be adapted for smaller, more deformable cells 
(such as immune cells) if needed. Using additional fabrication steps, two PDMS replicas 
could be bound together to form a symmetric channel, as done by others (see for example 
Lee et al.).35 Here we decided to prioritize simplicity of the design and fabrication, showing 
that nuclear deformability can be measured in asymmetric channels.
Automated image analysis
To measure nuclear deformations into the array of micropipettes in a quick and highly 
consistent manner, we developed a semi-automated MATLAB image analysis platform that 
requires only minimal user input (Figure 2). After initial image processing, a mask 
alignment step corrects the images for rotational error, segments the individual pockets, and 
determines the micropipette entrance (Figure 2B, vertical yellow line). To account for the 
heterogeneity in the nuclear fluorescence signal (e.g., DNA fluorescently labeled with 
Hoechst 33342), the user selects a binary threshold value for each pocket from a histogram 
of pixel count versus pixel intensity (Figure 2B, middle panel). Following additional erosion 
and dilation processing to smooth the segmented nuclei, the program tracks the leading edge 
of each nucleus (Figure 2B, red vertical line) and calculates the distance aspirated into the 
micropipette channel (i.e., the protrusion length) for each frame (Figure 2C). The program 
allows visual inspection of the nuclear protrusion length in each pocket before proceeding. 
The program exports the final matrix of nuclear protrusion values over time for each pocket 
as an Excel-compatible file for subsequent statistical analysis or curve fitting.
Characterization of fluid dynamics and pressure gradients with the microfluidic device
The velocity of the cells moving along the main channel depends on the difference between 
the applied pressures, PCell and PBuffer. The larger the pressure gradient, the faster the cells 
will move through the device, ensuring rapid filling of available pockets. The pressure 
difference across the micropipette channels drives the cell and nuclear deformation. This 
pressure gradient is determined by the pressure in the main channel in front of the pipette 
(which depends on PCell and PBuffer) and the atmospheric pressure, Patm, at the other end of 
the micropipette channel. The deformation rates and flow velocities are thus readily tunable 
by varying the pressures applied to the cell port (PCell) and the buffer port (PBuffer). To 
determine the pressure distribution within the device in more detail, including potential 
differences in the pressure exerted across the 18 parallel micropipette channels, we 
performed computational modeling of the fluid dynamics and pressure drop across the 
microfluidic device and then compared these model predictions with experimental 
measurements. We modeled two cases: one in which the micropipette channels are unfilled 
(“open”), and one in which the channels are blocked (“closed”). Typical experimental 
conditions during nuclear deformation measurements correspond to the “closed” scenario, as 
all of the micropipette channels are rapidly filled with cells that occupy the entire cross-
section of the channels (Figure 1E) and thereby block fluid flow across the microchannels, 
in agreement with previous work.46 In the closed case, the model predicts a linear decrease 
in pressure across the micropipette channels (Figure 3A, B), with the cells in the 
micropipette channels exposed to pressures between 3.8 and 4.4 kPa, corresponding to a 
difference of approximately 15% between the first and the last micropipette channel. In the 
case of the open micropipette channels, the model predicts a pressure drop across the main 
channel at the pipettes that decreases rapidly. In this case, the pressure difference from the 
first to the last micro-pipette channel decreases from 2.4 to 1.7 kPa (Supplemental Figure 1), 
a difference of >40%, which would imply a large variation from one micropipette channel to 
the next. In both the “open” and “closed” cases, the model indicates that the pressure drop 
across the filters at the ports is negligible compared to the pressure drop along the main 
channel (Figure 3A, B; large triangular shaped areas at each of the three outlets).
Experimental validation of the computational model
The small dimensions of the microfluidic device prohibit direct pressure measurements 
within the device. We therefore used experimental measurements of the fluid flow to infer 
the local pressure variation within the device. For these experiments, we perfused 
fluorescent beads through the microfluidic devices and determined the flow velocity inside 
the devices by quantifying the local velocity of the fluorescent beads. Measurements were 
obtained before and after the beads had clogged the microchannels, simulating the “open” 
and “closed” configurations, respectively. The experimental velocity measurements closely 
matched the predicted velocity from our computational model in the corresponding 
configurations (Figure 3B and Supp. Fig. 1). During actual micropipette aspiration 
experiments, all of the microchannels are simultaneously filled with cells, and thus 
experimental conditions resemble the “closed” case, resulting in a small, linear pressure drop 
along the length of the main channel. We tested whether the predicted small pressure 
difference between pipettes can affect the experimental readings depending on the position 
of the specific micropipette channel by performing experiments with mouse embryo 
fibroblast (MEF) cells and human breast cancer cells. The experiments did not reveal any 
statistically significant difference between the extent of nuclear deformation in the first 4 
channels of the devices compared to the last four channels for either of the cell lines (Figure 
3C; Suppl. Fig. 2A), indicating that the small drop in pressure along the main channel 
predicted by numerical simulations (Figure 3B) is negligible compared to the cell-to-cell 
variability of the experiment. If desired, the device design could be readily adapted to reduce 
further the pressure gradient across the section of the main channel containing the cell 
pockets, for example, by lengthening the other sections of the main channels, or altering its 
cross-section.
Device validation in cells with known nuclear mechanical properties
To validate our microfluidic micropipette devices, we measured the nuclear mechanical 
properties of lamin A/C-deficient (Lmna–/–) and wild-type (Lmna+/+) MEFs, which have 
been extensively characterized by micropipette aspiration5 and nuclear strain 
experiments1,47. Consistent with previous studies, we found that lamin A/C-deficient MEFs 
had significantly more deformable nuclei than wild-type MEFs, as evidenced by the 
substantially more rapid deformation into the micropipette channels (Figure 4). Lamin A/C-
deficient cells exhibited nuclear deformations 2.17 ± 0.02 times larger than wild-type 
controls, which is similar to the 2.05-fold increase in nuclear deformation observed in the 
same cell lines using substrate strain experiments,1 and the 2.2-fold increase reported in a 
previous study comparing lung epithelial cells depleted for lamin A/C to non-depleted 
controls.48
For a more detailed analysis of the mechanical properties of these two cell types, we 
compared the time-dependent nuclear deformation into the micropipette channels using two 
alternative approaches. In the first approach, we modeled nuclear deformation into the 
micropipette channels under a constant pressure (‘creep’) using a power law proposed by 
Dahl and colleagues.25 In this model, the nuclear protrusion length increases as a function of 
time to the power of an exponent, α, and the prefactor, A; the constant C accounts for 
uncertainty in the exact timing when the nucleus entered the channel (t = 0).
L t = A   tα + C
(3)
For viscoelastic materials, the exponent α is in the range of 0 to 1, and indicates whether the 
material behaviors more elastic (α closer to 0) or more viscous (α closer to 1).25 In our 
experiments (Figure 4B), lamin A/C-deficient and wild-type cells both fit power laws with 
similar exponents (α = 0.41 ± 0.01 and α = 0.37 ± 0.01 for wild-type cells and lamin A/C-
deficient cells, respectively). This value is comparable to the one found by Dahl et al.25 (α = 
0.3) for human adenocarcinoma-derived epithelial-like cells (TC7), and in agreement with a 
later study by the same group that found that reducing lamin A/C levels does not 
significantly affect the power law exponent for time-scales exceeding 10 seconds (α = 0.20 
for wild-type and 0.24 for lamin A/C-depleted lung epithelial cells).48 Taken together, our 
data indicate that the microfluidic devices produce results consistent with those obtained 
using conventional micropipette aspiration.
In a second approach, we used classical “spring and dashpot” viscoelastic models to 
describe the time-dependent nuclear deformation into the micropipette channels. We tested 
several combinations of springs and dashpots (see Suppl. Fig. 3). The simplest model to 
adequately fit the observed viscoelastic creep behavior (with an increasing plateau at long 
deformation times) is a dashpot in series with a Kelvin-Voigt element (spring and dashpot in 
parallel, Figure 4B). This 3-element model, known as a Jeffreys model, predicts the time-
dependent deformation by the following equation:
L t = fk 1 − e
−t τ + fμ2
t
(4)
where L(t) is the strain (or, in this case, the nuclear protrusion), f is the aspiration force, k is 
the spring constant, μ is the dissipation coefficient of the dashpot element in series and τ is 
the relaxation time (equivalent to k/μ1). To obtain quantitative data from this model, we 
balanced the aspiration force with the forces due to the elastic contribution (at short time 
scales) and the viscous flow through a small constriction (at long time scales) and obtained 
the following equation (see Supplementary Information for details on the derivation):
L t =
Re f f ΔP
E 1 − e
− E3πηt +
Re f f ΔP
3πη t
(5)
Fitting the experimental data to the Jeffreys model we obtained values comparable to those 
reported previously in the literature (Table 1). Guilak et al.49 measured an elastic modulus of 
1 kPa and a viscosity of 5 kPa*s in isolated nuclei of pig chondrocytes, Dahl et al.25 
measured an elastic modulus of 5.7 kPa in isolated nuclei from lung epithelial cells, and Luo 
et al50 found elastic moduli of 3.5 and 3 kPa in whole cell measurements of two tumor cell 
lines in microfluidic devices.
As expected, we detected significant differences between the lamin A/C-deficient and wild-
type cells (Table 1). The elastic modulus of wild-type nuclei was more than two times larger 
for the lamin A/C-deficient nuclei, indicative of the importance of lamin A/C in determining 
the resistance to nuclear deformation.1,4,13,17 Similarly, the two parameters describing the 
nuclear viscosity were approximately double in magnitude for wild-type cells compared to 
the lamin A/C-deficient cells, indicating that wild-type nuclei flow more slowly.
Both the Jeffreys model and the power law model closely matched the experimental data 
(Figure 4B) and present complementary approaches to analyze nuclear deformation data. 
Taken together, the above experiments demonstrate that the microfluidic device is well 
suited to study nuclear mechanical properties, including the time-dependent behavior of 
nuclear deformation under force. Given the similar quality of fit and the fact that both 
viscoelastic models use the same number of tunable parameters (A, α, and c for the power 
law model; E, η1, and η2 for the Jeffreys model), the choice of a particular model will 
depend on the specific experiments and questions.
The increased nuclear deformability of lamin A/C-deficient compared to wild-type MEFs 
matches results from a previous study examining the same cell lines using conventional 
micropipette aspiration.5 For a more detailed comparison, we conducted additional 
conventional micropipette aspiration on the same cell lines and fitted the data to the Jeffrey’s 
model to obtain values of the elasticity and viscosity parameters. Cells in both systems 
showed qualitatively similar aspiration dynamics (Suppl. Fig. 4). The quantitative 
comparison revealed a close match between the conventional micropipette aspiration and the 
microfluidic device data (see Supplementary Table 2).
Measurements are independent of nuclear size or DNA labeling
To test the robustness of the microfluidic analysis platform in measuring nuclear mechanical 
properties, we analyzed the effect of two potentially confounding factors: (1) nuclear size; 
(2) the Hoechst 33342 dye commonly used to fluorescently label DNA, which could
potentially affect nuclear deformability as it intercalates into the DNA. We found no
significant correlation between the measured mechanical properties of the nuclei and the size
of the nuclei (Suppl. Fig. 2C), indicating that the obtained measurements are independent of
nuclear size. Furthermore, the addition of Hoechst 33342 dye did not alter the nuclear
mechanical properties of cells expressing histone H2B fused to mNeonGreen to visualize
nuclear deformation (Suppl. Fig. 2B), indicating that the DNA-intercalating dye does not
alter mechanical properties under the experimental conditions used here.
Application of the device to laminopathy cells, stem cells, and tumor cells
To demonstrate the versatility of the microfluidic devices in a broad range of applications, 
we performed measurements of nuclear mechanical properties in a variety of cell types. In 
the first application, we compared human skin fibroblasts from an individual with dilated 
cardiomyopathy caused by a mutation in the LMNA gene (LMNA-DCM) with matching 
skin fibroblasts from a healthy family member.42 LMNA mutations lead to a wide family of 
diseases, collectively referred to as laminopathies, that include LMNA-DCM, Emery-
Dreifuss muscular dystrophy (EDMD), congenital muscular dystrophy, and limb-girdle 
muscular dystrophy.15 One hypothesis to explain the often muscle-specific phenotypes in 
laminopathies is that the mutations affect the mechanical properties of the nucleus, rendering 
it less stable, and thus resulting in increased cell death in mechanically stressed tissues such 
as skeletal and cardiac muscle.15 Supporting this hypothesis, fibroblasts expressing LMNA 
mutations associated with EDMD have more deformable nuclei than cells from healthy 
controls in membrane stretching assays.20 Applying our microfluidic platform to skin 
fibroblasts from a laminopathy patient with LMNA-DCM and from a healthy family 
member, we found that the LMNA-DCM skin fibroblasts had significantly more deformable 
nuclei than the healthy controls (Figure 5A Table 2), indicating that the LMNA mutation 
reduces the mechanical stability of the nucleus in the LMNA-DCM cells. Analysis of the 
time-dependent creep deformation revealed that the nuclei of the LMNA-DCM fibroblasts 
were less viscous than the healthy controls, as visible in the steeper slope of the nuclear 
protrusion over longer time scales (Figure 5A; Table 2). This trend recapitulates our above 
findings in the lamin A/C-deficient and wild-type MEFs, where the loss of lamin A/C 
reduced the nuclear elastic modulus and viscosities (Table 1). While further studies will be 
necessary to determine if these phenotypes are recapitulated in other mutations and in 
LMNA mutant human cardiomyocytes, we have already used the microfluidic assay to 
demonstrate that myoblasts from mouse models of muscle laminopathies have reduced 
nuclear stability, and that the extent of the defect correlates with the disease severity.51
In a second application, we investigated the effect of stem cell differentiation on nuclear 
mechanical properties. As pluripotent stem cells differentiate into specific lineages, their 
nuclear stiffness increases for most lineages, likely due to a concomitant increase in the 
expression levels of lamin A/C and changes in chromatin organization.10,22 We compared 
the deformability of human skin fibroblasts and induced-pluripotent stem cells (iPSCs) 
generated from skin fibroblasts, using our microfluidic devices. The iPSC cells had highly 
deformable nuclei (Figure 5A), resulting in many of the iPSCs passing through the 
micropipette channels within a few frames (less than 20 seconds). To avoid bias towards 
cells that passed through the channel more slowly, we restricted our comparison to the first 
60 seconds of nuclear deformation and selected only cells whose nuclei had not completely 
entered the micropipette channel during time. The iPSCs had significantly more deformable 
nuclei than the skin fibroblasts (Figure 5A; Table 2), consistent with a previous study using 
conventional micropipette aspiration that found that nuclear stiffness increased during 
differentiation of human embryonic stem cells22,52. Comparing the data to both the power 
law model and the Jeffreys model, we found that the Jeffreys model provided a better fit for 
the iPSC data than the power law model, whereas both models provided equally good fits for 
the human skin fibroblast data (Figure 5A), consistent with our results for mouse embryo 
fibroblasts (Figure 4). The error on the power law exponent value is orders of magnitude 
greater than the exponent itself, symptomatic of the poor fit. Strikingly, the viscosity (η2) of 
the iPSCs did not differ from the viscosity of the skin fibroblasts. This viscosity governs the 
deformation rate at long time scales. Our results suggest that reprogramming primary cells 
alters the elastic properties of the nuclei.
Taken together, these examples demonstrate the use of the microfluidic device to measure 
the viscoelastic properties of nuclei in intact cells in a broad range of applications, producing 
results consistent with conventional micropipette aspiration assays or nuclear strain 
experiments, but at significantly higher throughput, and without the need for cell-substrate 
adhesion. The latter point is particularly relevant when studying tumor cells, which often 
have reduced adhesion strength,53 and are thus not well suited for substrate strain 
experiments. Taking advantage of the novel microfluidic assay, we recently demonstrated 
that TGF-beta induced epithelial-to-mesenchymal transition in PyMT mouse breast tumor 
cells was associated with a decrease in nuclear stiffness, which, together with changes in 
focal adhesion organization, resulted in increased tumor cell invasion.54 Notably, the device 
can also be used to study nuclear envelope rupture, which frequently occurs during 
migration of cells through confined environments.26,41,55 As demonstrated in Figure 5B, the 
leakage of soluble green fluorescent protein with a nuclear localization sequence (NLS-
GFP)41 from the nucleus into the cytoplasm upon nuclear envelope rupture can be clearly 
observed during large nuclear deformations.
Outlook and conclusions
We developed a novel microfluidic device and semi-automated imaging analysis pipeline in 
which we can observe and quantify the deformation of the nucleus at high resolution in 
intact cells, and with at least 1–2 orders of magnitude higher throughput than conventional 
single cell micropipette aspiration experiments or atomic force microscopy measurements. 
Our device enables micropipette aspiration measurements that are practically uniform across 
the 18 micropipette channels. Scaling up the device to include more micropipette channels 
could further increase the throughput, but would result in a larger difference in the pressure 
gradient between the first and last channel, thereby increasing experimental variability. 
Design modifications could counteract such variations in the pressure gradient between 
individual micropipette channels. For example, rather than applying a uniform pressure 
(Patm) at the channel outlets, one could apply a pressure gradient across the outlets of the 
channels, so that the pressure gradient along each channel is identical. However, such a 
design would require additional pressure controllers. Alternatively, increasing the total 
length of the main channel would create a shallower gradient, which would reduce the 
difference in pressure from one micropipette channel to the next. Lastly, the operation of the 
device could be altered to increase the pressure at the buffer port to the same value as the 
cell port once all pockets have been filled with cells, eliminating the pressure gradient along 
the main channel, but this approach would require more interactive user intervention and 
may result in slight changes in pressure gradients during the experiment. In the current form, 
our compact design allows the experiment to be carried out at one position, limiting 
alignment and focusing difficulties involved in changing positions, while allowing large 
numbers of cells to be analyzed due to our ability to rapidly clear out the channels at the end 
of one run. This design is thus best suited for our purposes: it is easy to use and achieves 
substantially more nuclear deformation measurements in a smaller amount of time than 
conventional micropipette aspiration.
We demonstrated the device’s applicability to obtain precise viscoelastic information about 
the nucleus, including in mouse and human laminopathy cells and in human induced 
pluripotent stem cells and the corresponding original skin fibroblasts. Because the analysis 
platform presented here can perform measurements on large populations of cells, it can 
characterize the heterogeneity of samples, for example, to detect small mechanically distinct 
subpopulations of cancer cells or stem cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1: 
Overview of the micropipette devices. (A) Schematic overview of the device and the 
different pressures applied to the three ports. The dashed rectangle indicates the region 
shown as close-up in panels C and D. (B) Photograph of the actual devices in a typical 
experimental setup, with four devices mounted on a glass coverslip, allowing the 
measurement of four different cell types or replicates in rapid succession. A US 1 cent coin 
serves as reference for size. (C) Schematic 3-D close-up of the micropipette channels and 
the main channel, corresponding to the area outlined with a dashed line in panel A. (D) 
Schematic close-up of the device region with the individual pipettes channels, viewed from 
the top (left) and side (right). The side-view shows that the pipette channels have a lower 
height (5 μm) than the rest of the device (10 μm). (E) Representative image of cells 
expressing fluorescently labeled histones (red) to reveal the nucleus, and a fluorescent actin 
marker (LifeAct-GFP, green) to delineate the cytoplasm, entering the micropipette channel. 
(Scale bar 10 μm.)
Figure 2: 
Custom-designed MATLAB software enables rapid analysis of nuclear deformability. (A) 
Schematic overview of the image analysis pipeline. The MATLAB program converts time-
lapse micropipette aspiration movies into multidimensional image stacks and separates them 
by color channel. The user aligns a mask to one of the image frames to segment the 18 
pockets, enabling individual examination of each cell nucleus. (B) A graphical user interface 
ensures accurate measurement of the nuclear deformations within each pipette. The yellow 
box (left panel, fourth pocket) indicates the selected cell and corresponding nucleus, as 
visualized using Hoechst 33342 dye, which fluorescently labels DNA. The user sets a binary 
threshold value (blue dotted line) by clicking within the middle panel, a 60-bin histogram of 
image intensity values. Clicking the left mouse button previews the threshold by playing 
through the image sequence (right panel) at a user-specified sampling rate (every nth frame). 
Additional erosion and dilation processing steps smooth boundaries and remove spurious 
pixels within the thresholded image. The program computes the nuclear protrusion length at 
each frame by drawing a bounding box around the thresholded nucleus (red box) and then 
computing the distance between the left edge (red vertical line) and the start of the 
micropipette channel (yellow vertical line). Once the thresholded image sequence (right 
panel, bottom) accurately depicts the original (right panel, middle), right clicking the mouse 
button saves the protrusion length values and proceeds to the next pocket. The values are 
exported to an Excel file where they can be plotted and analyzed. (C) A plot of the nuclear 
protrusion length over time for a given cell, with the red data points corresponding to the 
thresholded nuclei in the frames shown below.
Figure 3: 
Modeling of the pressure distribution across the device. (A) Pressure distribution obtained 
from 3-D computational model in the condition in which the micropipette channels are 
closed, corresponding to experimental conditions in which all the channels are blocked by 
cells. (B) Comparison of the model predictions for the pressure distribution and resulting 
fluid velocity distribution in the main channel with experimental measurements. The 
velocity (light green line) determined from the pressure gradient (top figure and blue curve) 
was compared to the flow velocity determined from fluorescent beads (dark green points). 
(C) Deformation of wild-type MEFs in the first four micropipette channels (blue) compared
to the last four micropipette channels (red). The differences between the first four and the
last four channels is not statistically significant, consistent with the predictions of the
models. Similar results obtained from independent experiments with another cell line are
included in Supp. Fig. 2A.
Figure 4: 
Validation of the devices the mechanical properties of nuclei. Wild-type (Lmna+/+, left) and 
lamin A/C-deficient (Lmna–/–, right) cells were deformed and the length of the protrusion 
was measured as a function of time. Brightfield images and images of the nucleus stain 
(Hoechst 33342) were acquired every five seconds. The lamin A/C-deficient cells deformed 
more rapidly and more extensively than the wild-type controls. (A) Representative example 
images of the same cell at three different time points. (Scale bar 20 μm.) See Suppl. Movies 
2 and 3 for representative image sequences. (B) The nuclear deformation (protrusion length) 
as a function of time modelled as a power law (purple line) or using the Jeffreys model (red 
dashed line). Only the first 120 seconds are shown for the Lmna–/– cells as many of these 
nuclei completely entered the micropipette channel at times longer than 120 seconds, and 
could thus not be used for analysis. (C) Comparison of the nuclear protrusion length at 120 
seconds. ***, p < 0.001; n = 70 and 56 for Lmna+/+ and Lmna–/–, respectively).
Figure 5: 
Comparison of the deformability of human cells. (A) Induced pluripotent stem cells derived 
from human skin fibroblasts have more deformable nuclei than human skin fibroblasts, 
reflecting the changes in chromatin organization and lower lamin A/C levels in the iPSCs. 
Human skin fibroblasts from an individual carrying a LMNA mutation that causes dilated 
cardiomyopathy have significantly more nuclear viscous flow at long deformation times. (B) 
Extensive nuclear deformation micropipette aspiration can result in nuclear envelope 
rupture, as visualized by the leakage of soluble green fluorescent proteins with a nuclear 
localization sequence (NLS-GFP) into the cytoplasm following nuclear envelope rupture. 
Time-lapse images show the extent of deformation and nuclear leakage with time, as a 
function of the onset of nuclear deformation. (Scale bar 20 μm.)
Table 1.
Lamin A/C-deficient cells have altered nuclear viscoelastic properties. Parameters for the Jeffreys model based 
on the least squares regression of the experimental data. The parameters A and α were obtained by measuring 
the protrusion length in μm and the time in seconds. The units of the parameter A are dependent on the 
magnitude of α; α is dimensionless.
Parameter Lmna+/+ Lmna–/–
A 1.34 (±0.05) 3.8 (±0.3)
α 0.41 (±0.01) 0.37 (±0.01)
E 2.7 (±0.5) kPa 1.3 (±0.3) kPa
η1 8 (±1) kPa*s 4 (±1) kPa*s
η2 40 (±10) kPa*s 18 (±4) kPa*s
Table 2.
Cells bearing LMNA mutations and in a reprogrammed differentiation state show altered nuclear mechanics. 
Parameters for Jeffreys model based on best fit to the experimental data from human skin fibroblasts from an 
individual with an LMNA mutation associated with dilated cardiomyopathy (DCM), a healthy control, and 
iPSCs derived from healthy human skin fibroblasts. The parameters A and α were obtained by measuring the 
protrusion length in μm and the time in seconds. The units of the parameter A are dependent on the magnitude 
of α; α is dimensionless.
Healthy fibro DCM fibro iPSC
A 1.02 (±0.05) 0.83 (±0.02) 19 (±2)
α 0.49 (±0.01) 0.584 (±0.004) 0.012 (±200)
E 2.5 (±0.2) kPa 2.2 (±0.2) kPa 1.0 (±0.1) kPa
η1 8 (±1) kPa*s 9 (±1) kPa*s 0.7 (±0.1) kPa*s
η2 30 (±2) kPa*s 22 (±2) kPa*s 21 (±2) kPa*s
